Analyst Reco. Hikma Pharmaceuticals PLC

Equities

Market Closed - London S.E. Other stock markets 16:35:19 29/04/2024 BST			5-day change	1st Jan Change
1,930 ^GBX	+0.89%		+6.16%	+7.88%

04-26	HIKMA PHARMACEUTICALS : Hikma’s Q1 progress appreciated by the markets
04-25	Hikma Pharmaceuticals plc Approves Final Dividend, Payable on 3 May 2024	CI

HIKMA PHARMACEUTICALS : Hikma’s Q1 progress appreciated by the markets	04-26
RBC Keeps Hikma Pharmaceuticals at Sector Perform, Raises PT	02-29	MT
Barclays cuts Direct Line to equal weight	02-29	AN
Barclays raises Breedon but cuts Domino's Pizza	02-23	AN
HIKMA PHARMACEUTICALS : Strong Generics-led finish to 2023	02-22
JPMorgan Keeps Hikma Pharmaceuticals at Overweight, Raises PT	02-22	MT
Berenberg raises Moneysupermarket.com to 'buy'	02-22	AN
RBC Raises Hikma Pharmaceuticals PT, Affirms Sector Perform Rating	01-09	MT
Berenberg cuts target prices for miners	01-09	AN
HIKMA PHARMACEUTICALS : Incorporating a healthy ongoing recovery	01-08
Jefferies Reduces Hikma Pharmaceuticals PT, Keeps at Hold	12-20	MT
UBS cuts DS Smith; Kepler likes Genus	12-20	AN
Barclays Keeps Hikma Pharmaceuticals at Equalweight, Lowers PT	12-19	MT
Peel Hunt raises Flutter to 'buy' from 'hold'	12-19	AN
JPMorgan Trims Hikma Pharmaceuticals PT, Keeps Overweight Rating	12-05	MT
Goldman lifts Landsec and British Land	12-05	AN
Jefferies Downgrades Hikma Pharmaceuticals to Hold from Buy, Trims PT	11-07	MT
Hikma's Generics Recovery Remains Uncertain Despite Upgraded Outlook, Berenberg Says	11-07	MT
Watches of Switzerland impresses HSBC; Asos cut	11-07	AN
HIKMA PHARMACEUTICALS : Healthy Q3; Injectables’ temporary constraints shouldn’t be a worry	11-03

No results for this search

HIKMA PHARMACEUTICALS : Hikma’s Q1 progress appreciated by the markets

April 26, 2024 at 11:50 am